安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- What is COPD? - Chronic Obstructive Pulmonary Disease - COPD Foundation
Chronic Obstructive Pulmonary Disease (COPD) is a term used to describe chronic lung diseases including emphysema, and chronic bronchitis This disease is characterized by breathlessness COPD is (currently) an incurable disease, but with the right diagnosis and treatment, there are many things you can do to breathe better and enjoy life and live for many years
- COPD Foundation | Learn More, Take Action and Breathe Better
The COPD Foundation’s mission is to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease
- COPD - What Is COPD? | NHLBI, NIH
COPD Basics Learn who is at risk for COPD, what symptoms to watch for, and how the disease affects the lungs COPD, or chronic obstructive pulmonary disease, is a condition caused by damage to the airways or other parts of the lung This damage leads to inflammation and other problems that block airflow and make it hard to breathe
- COPD - Causes and Risk Factors | NHLBI, NIH
Causes and Risk Factors of COPD Learn about NHLBI research to help understand why some people get COPD or get more severe COPD than others
- COPD Treatment and Medications | COPD Foundation
COPD treatments include medication, pulmonary rehabilitation, smoking vaping cessation support, immunizations, medical procedures, and other therapies Let's learn more about the different treatment options for COPD COPD Medications There are many different types of COPD medications, including short- and long-acting bronchodilators, inhaled and systemic corticosteroids, and antibiotics For
- COPD - Symptoms | NHLBI, NIH
Symptoms of COPD include shortness of breath, cough, wheezing, chest tightness, and fatigue These can get worse over time Sudden flare-ups of symptoms are called exacerbations You should seek medical attention when symptoms occur
- A New COPD Treatment is FDA Approved
This article was written by Jonnie Korinko, MSRC, RRT, RRT-ACCS On June 26, 2024, Verona Pharmaceuticals announced that its new medication, Ensifentrine (Ohtuvayre), was approved by the U S Food and Drug Administration (FDA) for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) See the press release here Ensifentrine works in two main ways to help people breathe
- COPD Flare-Ups: Warning Signs, Prevention, and Management
Avoid triggers: COPD flare-ups can be caused by things in the environment like pollution, breathing in dust, or smoke from tobacco or wood Smoking, including cigarettes, cigars, pipes, and vaping, can increase your risk of a flare-up
|
|
|